NCT00758459 - Safety/Tolerability Study With AZD1236 in Chronic Obstructive Pulmonary Disease (COPD) Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2008

Study Completion Date

March 31, 2009

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

DRUG

AZD1236

oral tablet, 75 mg, twice daily during 6 weeks

DRUG

Placebo

Dosing to match AZD1236

Trial Locations (14)

Research Site, Rousse

Research Site, Sofia

Research Site, Helsinki

Research Site, Oulu

Research Site, Preitilä

Research Site, Berlin

Research Site, Grobhansdorf

Research Site, Győr

Research Site, Komló

Research Site, Pécs

Research Site, Vásárosnamény

Research Site, Bojnice

Research Site, Liptovský Hrádok

Research Site, Žilina